Summit Therapeutics (SMMT) Debt Ratio (2022 - 2024)

Summit Therapeutics (SMMT) has reported Debt Ratio for 3 consecutive years, with 0.57 the latest figure, recorded in Q1 2024.

• Quarterly Debt Ratio rose 44.19% year-over-year to 0.57 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.57 (up 44.19% YoY) and the FY2023 annual result came in at 0.49, down 33.83% from the prior year.
• Debt Ratio improved to 0.57 in Q1 2024 per SMMT's latest filing, from 0.49 in the prior quarter.
• Over the last five years, Debt Ratio for SMMT reached as high as 0.74 in Q4 2022 and fell as low as 0.22 in Q1 2022.
• A 3-year average of 0.44 and a median of 0.42 in 2023 frame the typical range for Debt Ratio.
• The largest YoY upside for Debt Ratio was 82.37% in 2023 against a maximum downside of 33.83% in 2023.
• Year by year, Debt Ratio stood at 0.74 in 2022, then sank by 33.83% to 0.49 in 2023, then gained by 14.8% to 0.57 in 2024.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.57, 0.49, and 0.42 for Q1 2024, Q4 2023, and Q2 2023 respectively.